Drugs / Metoprolol succinate ER
last change Jun 2008 re-read 3 minutes ago

Metoprolol succinate ER

Developed for
chronic obstructive pulmonary disease
Investigated by
AstraZeneca · VA Greater Los Angeles Healthcare System

Trials 1

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03370835 Jun 2004 → Jun 2008 asthma, chronic obstructive pulmonary disease VA Greater Los Angeles Healthcare System Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Metoprolol succinate ER ClinicalTrials.gov intervention name — accepted as the source's own label NCT03370835 ↗
Action Inhibit “selective beta-1 receptor beta-blocker” NCT03370835 ↗